EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer

Bokyung Kim, Harim Chun, Jongwon Lee iD, Miree Park, Yoonjin Kwak, Jung Mogg Kim, Sang Gyun Kim, Ji Kon Ryu iD, Jungmin Choi, Soo-Jeong Cho iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Bokyung Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seou…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Neoplasms, Second Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Research Foundation of Korea, The Korean College of Helicobacter and Upper Gastrointestinal Research Foundation, SNUH research fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to identify predictive markers for metachronous gastric cancer (MGC) in early gastric cancer (EGC) patients curatively treated with endoscopic submucosal dissection (ESD). Materials and Methods From EGC patients who underwent ESD, bulk RNA sequencing was performed on non‐cancerous gastric mucosa samples at the time of initial EGC diagnosis. This included 23 patients who developed MGC, and 23 control patients without additional gastric neoplasms for over 3 years (1:1 matched by age, sex, and Helicobacter pylori infection state). Candidate differentially‐expressed genes were identified, from which biomarkers were selected using real‐time quantitative polymerase chain reaction and cell viability assays using gastric cell lines. An independent validation cohort of 55 MGC patients and 125 controls was used for marker validation. We also examined the severity of gastric intestinal metaplasia, a known premalignant condition, at initial diagnosis.

Results

From the discovery cohort, 86 candidate genes were identified of which KDF1 and CDK1 were selected as markers for MGC, which were confirmed in the validation cohort. CERB5 and AKT2 isoform were identified as markers related to intestinal metaplasia and were also highly expressed in MGC patients compared to controls ( p < 0.01). Combining these markers with clinical data (age, sex, H. pylori and severity of intestinal metaplasia) yielded an area under the curve (AUC) of 0.91 (95% CI, 0.85‐0.97) for MGC prediction.

Conclusion

Assessing biomarkers in non‐cancerous gastric mucosa may be a useful method for predicting MGC in EGC patients and identifying patients with a higher risk of developing MGC, who can benefit from rigorous surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorNeoplasms, Second PrimaryHumansMaleFemaleMiddle AgedAgedEndoscopic Mucosal ResectionCDC2 Protein KinaseGastric MucosaHelicobacter InfectionsGastroscopyGene Expression Regulation, NeoplasticMetaplasiaHelicobacter pyloriCase-Control Studies

Stichwörter der Autor:innen

RNA sequencingbiomarkersendoscopic resectiongastric cancerwhole exome sequencing

Substanzen

Biomarkers, TumorCDC2 Protein KinaseCDK1 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Department of Microbiology, Hanyang University College of Medicine, Seoul, Korea.

ORCID-Profile: Jongwon Lee, Ji Kon Ryu, Soo-Jeong Cho

Förderung

  • The National Research Foundation of Korea
  • The Korean College of Helicobacter and Upper Gastrointestinal Research Foundation
  • SNUH research fund
  • The Basic Science Research Program through the National Research Foundation of Korea (NRF)
  • The Seoul National University College of Medicine Research foundation

Zitieren

APA

Kim, B., Chun, H., Lee, J., Park, M., Kwak, Y., Kim, J. M., Kim, S. G., Ryu, J. K., Choi, J., & Cho, S. J. (2024). Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70104

Vancouver

Kim B, Chun H, Lee J, Park M, Kwak Y, Kim JM, et al. Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70104

BibTeX
@article{Kim2024,
  author = {Kim, Bokyung and Chun, Harim and Lee, Jongwon and Park, Miree and Kwak, Yoonjin and Kim, Jung Mogg and Kim, Sang Gyun and Ryu, Ji Kon and Choi, Jungmin and Cho, Soo-Jeong},
  title = {Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70104}
}
Kostenlos starten →